|Articles|July 29, 2022
TrialCard Names Scott Dulitz Chief Executive Officer
Founded in 2000, TrialCard is a life sciences commercialization company that provides a comprehensive suite of solutions to over 400 pharma, biotech, and medtech companies.
Advertisement
TrialCard Incorporated, a full-service life sciences commercialization partner, today announced that Scott Dulitz has been promoted to Chief Executive Officer by the Company's Board of Directors. Mr. Dulitz, a twenty-year veteran of the pharma services industry, joined TrialCard in 2015 and most recently served as President and Chief Strategy Officer.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Vinay Prasad Out at CBER for Second Time in Under a Year
2
Key Factors Contributing to Uncertainty in Moderna's mRNA Vaccine Review
3
Ipsen Withdraws Tazverik from Market Due to Emerging Data from Clinical Trial
4
Novo Nordisk Signs Deal with Hims & Hers
5